- Home
- IBP vs CORT Comparison
IBP vs CORT Comparison
Compare IBP & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBP
- CORT
- Stock Information
- Founded
- IBP 1977
- CORT 1998
- Country
- IBP United States
- CORT United States
- Employees
- IBP N/A
- CORT N/A
- Industry
- IBP Homebuilding
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- IBP Consumer Discretionary
- CORT Health Care
- Exchange
- IBP Nasdaq
- CORT Nasdaq
- Market Cap
- IBP 6.9B
- CORT 7.6B
- IPO Year
- IBP 2014
- CORT N/A
- Fundamental
- Price
- IBP $247.47
- CORT $74.17
- Analyst Decision
- IBP Hold
- CORT Strong Buy
- Analyst Count
- IBP 9
- CORT 4
- Target Price
- IBP $218.75
- CORT $139.00
- AVG Volume (30 Days)
- IBP 397.3K
- CORT 938.5K
- Earning Date
- IBP 11-05-2025
- CORT 11-04-2025
- Dividend Yield
- IBP 1.29%
- CORT N/A
- EPS Growth
- IBP 3.14
- CORT N/A
- EPS
- IBP 9.28
- CORT 0.87
- Revenue
- IBP $2,973,500,000.00
- CORT $741,172,000.00
- Revenue This Year
- IBP N/A
- CORT $28.85
- Revenue Next Year
- IBP $1.22
- CORT $34.98
- P/E Ratio
- IBP $26.48
- CORT $87.75
- Revenue Growth
- IBP 2.12
- CORT 17.92
- 52 Week Low
- IBP $150.83
- CORT $49.00
- 52 Week High
- IBP $280.00
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- IBP 44.89
- CORT 47.01
- Support Level
- IBP $230.94
- CORT $67.00
- Resistance Level
- IBP $270.00
- CORT $77.01
- Average True Range (ATR)
- IBP 11.08
- CORT 3.15
- MACD
- IBP -2.28
- CORT 0.03
- Stochastic Oscillator
- IBP 35.74
- CORT 53.91
About IBP Installed Building Products Inc.
Installed Building Products Inc is an insulation installer serving the residential new construction market and are also a diversified installer of complementary building products, including waterproofing, fire-stopping and fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving, mirrors and other products throughout the United States. The company installs fiberglass insulation, spray foam insulation, and cellulose insulation. The company has three operating segments consisting of Installation, Manufacturing and Distribution operations. Majority of revenue is derived from Installation segment.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.